Macroeconomic Developments Will Aid in Bone Metastasis Therapeutics Market Growth
According to study results from Minneapolis Medical Research Foundation, in 2012, over 280,000 patients were living with bone metastasis in the U.S. with breast and prostate cancers being the most common primary tumor types.
View full press release